News

Metabolic monitoring suboptimal for dementia patients taking antipsychotics

Publish date: April 14, 2015

 

AT THE AAGP ANNUAL MEETING

References

Dr. Mittal had no financial disclosures.

msullivan@frontlinemedcom.com

On Twitter @alz_gal

Pages

Recommended Reading

Microbiome may drive the course of diabetes, obesity
MDedge Internal Medicine
Cardiovascular safety evidence for alogliptin reassuring
MDedge Internal Medicine
Anticipation runs high for coming megatrials in general cardiology
MDedge Internal Medicine
Updated IMPROVE-IT results show bigger benefits
MDedge Internal Medicine
Recommended statin use in young adults greatly expanded under pediatric rules
MDedge Internal Medicine
Genetic link validated between shorter height, coronary artery disease
MDedge Internal Medicine
Antimalarial drugs reduced instances of metabolic syndrome in lupus patients
MDedge Internal Medicine
CCND2 variant improves insulin secretion and sensitivity
MDedge Internal Medicine
Screening adults for diabetes doesn’t lessen mortality
MDedge Internal Medicine
Heart failure spurs 'cardiogenic diabetes'
MDedge Internal Medicine